ClinicalTrials.gov
ClinicalTrials.gov Menu

3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00159796
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : May 31, 2017
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.